CLEARONE INC CLRO
Nasdaq · XNAS · stock · Telephone & Telegraph Apparatus
Chart by TradingView
1/9
Piotroski F — financial health
-63.75
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $0 | -$26.1M | -$328,000 | — | -$714,000 |
| 2024 | $0 | -$9.0M | -$194,000 | -$9.1M | $21.3M |
| 2023 | $18.7M | -$560,000 | $6.4M | $54.3M | $44.7M |
| 2022 | $25.2M | $20.6M | $9.5M | -$4.2M | $74.1M |
| 2021 | $29.0M | -$7.7M | $11.9M | -$4.6M | $51.5M |
| 2020 | $29.1M | $505,000 | $12.6M | -$1.3M | $49.8M |
Why these scores methodology →
Piotroski F-score: 1/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -63.75 (distress)
- Working capital / assets 0.091
- Retained earnings / assets -15.721
- EBIT / assets -1.912
- Equity / liabilities -0.237
Source: SEC EDGAR filings · CIK 0000840715 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.